β-Cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release

被引:235
作者
Franklin, I
Gromada, J
Gjinovci, A
Theander, S
Wollheim, CB [1 ]
机构
[1] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland
[2] Lilly Res Labs, Hamburg, Germany
关键词
D O I
10.2337/diabetes.54.6.1808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon, secreted from islet alpha-cells, mobilizes liver glucose. During hyperglycemia, glucagon secretion is inhibited by paracrine factors from other islet cells, but in type 1 and type 2 diabetic patients, this suppression is lost. We investigated the effects of beta-cell secretory products zinc and insulin on isolated rat a-cells, intact islets, and perfused pancreata. Islet glucagon secretion was markedly zinc sensitive (IC50 = 2.7 mu mol/l) more than insulin release (IC50 = 10.7 mu mol/l). Glucose, the mitochondrial substrate pyruvate, and the ATP-sensitive K+ channel (K-ATP channel) inhibitor tolbutamide stimulated isolated alpha-cell electrical activity and glucagon secretion. Zinc opened K-ATP channels and inhibited both electrical activity and pyruvate (but not arginine) stimulated glucagon secretion in alpha-cells. Insulin transiently increased K-ATP channel activity, inhibited electrical activity and glucagon secretion in alpha-cells, and inhibited pancreatic glucagon output. Insulin receptor and K-ATP channel subunit transcripts were more abundant in alpha- than beta-cells. Transcript for the glucagon-like peptide 1 (GLP-1) receptor was not detected in alpha-cells nor did GLP-1 stimulate a-cell glucagon release. beta-Cell secretory products zinc and insulin therefore inhibit glucagon secretion most probably by direct activation of K-ATP channels, thereby masking an alpha-cell metabolism secretion coupling pathway similar to beta-cells.
引用
收藏
页码:1808 / 1815
页数:8
相关论文
共 50 条
  • [21] Holst JJ, 2003, ADV EXP MED BIOL, V524, P263
  • [22] Islet β-cell secretion determines glucagon release from neighbouring α-cells
    Ishihara, H
    Maechler, P
    Gjinovci, A
    Herrera, PL
    Wollheim, CB
    [J]. NATURE CELL BIOLOGY, 2003, 5 (04) : 330 - 335
  • [23] Glucagon and regulation of glucose metabolism
    Jiang, GQ
    Zhang, BB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (04): : E671 - E678
  • [24] COMPARISON OF THE EFFECTS OF GLUCAGON-LIKE PEPTIDE-1-(1-37) AND PEPTIDE-(7-37) AND GLUCAGON ON ISLET HORMONE-RELEASE FROM ISOLATED PERFUSED CANINE AND RAT PANCREASES
    KAWAI, K
    SUZUKI, S
    OHASHI, S
    MUKAI, H
    OHMORI, H
    MURAYAMA, Y
    YAMASHITA, K
    [J]. ENDOCRINOLOGY, 1989, 124 (04) : 1768 - 1773
  • [25] Insulin activates ATP-sensitive K+ channels in pancreatic β-cells through a phosphatidylinositol 3-kinase-dependent pathway
    Khan, FA
    Goforth, PB
    Zhang, M
    Satin, LS
    [J]. DIABETES, 2001, 50 (10) : 2192 - 2198
  • [26] GLUCAGONOSTATIC AND INSULINOTROPIC ACTION OF GLUCAGON-LIKE PEPTIDE I-(7-36)-AMIDE
    KOMATSU, R
    MATSUYAMA, T
    NAMBA, M
    WATANABE, N
    ITOH, H
    KONO, N
    TARUI, S
    [J]. DIABETES, 1989, 38 (07) : 902 - 905
  • [27] Autometallography allows ultrastructural monitoring of zinc in the endocrine pancreas
    Kristiansen, LH
    Rungby, J
    Sondergaard, LG
    Stoltenberg, M
    Danscher, G
    [J]. HISTOCHEMISTRY AND CELL BIOLOGY, 2001, 115 (02) : 125 - 129
  • [28] Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis
    Maechler, P
    Wollheim, CB
    [J]. NATURE, 1999, 402 (6762) : 685 - 689
  • [29] INSULIN WITHIN ISLETS IS A PHYSIOLOGIC GLUCAGON-RELEASE INHIBITOR
    MARUYAMA, H
    HISATOMI, A
    ORCI, L
    GRODSKY, GM
    UNGER, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) : 2296 - 2299
  • [30] Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes
    Meneilly, GS
    McIntosh, CHS
    Pederson, RA
    Habener, JF
    Ehlers, MRW
    Egan, JM
    Elahi, D
    [J]. DIABETES CARE, 2003, 26 (03) : 837 - 842